kidney disease glp-1 news Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists GLP-1 receptor agonists and next-generation

Description

Both its dual-agonist injectable poterepatide and its oral small molecule conveglipron are in Phase III, demonstrating significant late-stage momentum

Gastroparesis is a chronic gastrointestinal condition that happens when the stomach cant empty well, causing delayed digestion and related symptoms.

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints

Patent-pending XOSM technology

US gut health company Pendulum Therapeutics has introduced Gut Fuel, a doctor-formulated prebiotic fibre and polyphenol powder combining resistant potato starch, baobab, acacia, oat beta-glucan and grape seed extract to support the microbiome, metabolic function and natural GLP-1 pathways